FSMAX
Price
$81.49
Change
+$2.00 (+2.52%)
Updated
Apr 24 closing price
Net Assets
36.55B
WSMNX
Price
$21.73
Change
+$0.39 (+1.83%)
Updated
Apr 24 closing price
Net Assets
1.37B
Ad is loading...

FSMAX vs WSMNX

Header iconFSMAX vs WSMNX Comparison
Open Charts FSMAX vs WSMNXBanner chart's image
Fidelity Extended Market Index
Price$81.49
Change+$2.00 (+2.52%)
VolumeN/A
Net Assets36.55B
William Blair Small-Mid Cap Growth N
Price$21.73
Change+$0.39 (+1.83%)
VolumeN/A
Net Assets1.37B
FSMAX vs WSMNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSMAX vs. WSMNX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a StrongBuy and WSMNX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 36.5B vs. WSMNX (1.37B). FSMAX pays higher dividends than WSMNX: FSMAX (0.53) vs WSMNX (0.00). FSMAX was incepted earlier than WSMNX: FSMAX (14 years) vs WSMNX (21 years). WSMNX (1.37) is less costly to investors than FSMAX (0.04). WSMNX is a more actively managed with annual turnover of: 63.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than WSMNX: FSMAX (0) vs WSMNX (2500). FSMAX annual gain was more profitable for investors over the last year : 0.98 vs. WSMNX (-18.70). FSMAX return over 5 years is better than : 66.04 vs. WSMNX (-3.53).
FSMAXWSMNXFSMAX / WSMNX
Total Expense Ratio0.041.243%
Annual Report Gross Expense Ratio0.041.373%
Fund Existence14 years21 years-
Gain YTD-12.533-15.68580%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets36.5B1.37B2,656%
Annual Yield % from dividends0.530.00-
Returns for 1 year0.98-18.70-5%
Returns for 3 years10.93-22.12-49%
Returns for 5 years66.04-3.53-1,873%
Returns for 10 years49.785.38925%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SABS1.500.13
+9.49%
SAB Biotherapeutics
XMTR24.861.06
+4.45%
Xometry
CBOE212.681.26
+0.60%
Cboe Global Markets
SR77.960.45
+0.58%
Spire
CRDF2.90-0.04
-1.36%
Cardiff Oncology